Company Luckycom Inc OTC Bulletin Board

US54959R1086

Investment Holding Companies

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Shell Companies

Inactive Instrument

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

2021	Luckwel Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended June 30, 2020	CI
2021	Luckwel Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended March 31, 2020	CI

Luckwel Pharmaceuticals Inc. creates medicine to cure diseases. The Company is focused on autoimmune disease, human immunodeficiency virus (HIV) / acquired immune deficiency syndrome (AIDS) and infectious diseases. The Companyâs pipelines include LWEL-2120 for the treatment of rheumatoid arthritis (RA), LWEL-2119 for the treatment of HIV and LWEL-2103 for the treatment of COVID-19.

Managers	Title	Age	Since
Kingrich Lee CEO	Chief Executive Officer	49	01/01/13
Mark Carrao DFI	Director of Finance/CFO	-	31/08/21
Michael Silverman CTO	Chief Tech/Sci/R&D Officer	-	-
Priya Jambhekar LAW	General Counsel	-	-

Members of the board	Title	Age	Since
Kingrich Lee CEO	Chief Executive Officer	49	01/01/13

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	147,163,500	14,931,388 ( 10.15 %)	0	10.15 %

Luckwel Pharmaceuticals, Inc.

125 Cambridge Park Drive Suite 301

02140, Cambridge

+617 430 5222

http://www.luckwel.com

Financials

Holding Companies

Holding Companies

Investment Holding Companies

Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+111.71%	6.55B
APPLE ISPORTS GROUP, INC.	+98.02%	1.23B
CHURCHILL CAPITAL CORP VII	+2.52%	986M
PERELLA WEINBERG PARTNERS	+14.96%	752M
ARES ACQUISITION CORPORATION II	+2.11%	666M
E7 GROUP	+2.33%	620M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ADMIRAL ACQUISITION LIMITED	+8.61%	528M
CAPITOL INVESTMENT CORP. VII	-.--%	500M

Shell Companies